Estimating global trends in total and childhood antibiotic consumption, 2011-2015
Open Access
- 27 February 2019
- journal article
- research article
- Published by BMJ in BMJ Global Health
- Vol. 4 (1) , e001241
Abstract
Introduction: Understanding patterns of antibiotic consumption is essential to ensure access to appropriate antibiotics when needed and to minimise overuse, which can lead to antibiotic resistance. We aimed to describe changes in global antibiotic consumption between 2011 and 2015. Methods: We analysed wholesale data on total antibiotic sales and antibiotics sold as child-appropriate formulations (CAFs), stratified by country income level (low/middle-income and high-income countries (LMICs and HICs)). The volume of antibiotics sold per year was recorded for 36 LMICs and 39 HICs, measured in standard units (SU: 1 SU is equivalent to a single tablet, capsule or 5 mL ampoule/vial/oral suspension) and SU per person, overall and as CAFs. Changes over time were quantified as percentage changes and compound annual growth rates in consumption per person. Analyses were conducted separately for total sales, sales of antibiotics in the Access and Watch groups of the WHO’s Essential Medicines List for children 2017, for amoxicillin and amoxicillin with clavulanic acid. Results: Antibiotic consumption increased slightly between 2011 and 2015, from 6.85×1010 SU to 7.44×1010 SU overall and from 1.66×1010 SU to 1.78×1010 SU for CAFs. However, trends differed between countries and for specific antibiotics; for example, consumption of amoxicillin as CAFs changed little in LMICs and HICs, but that of amoxicillin with clavulanic acid increased by 6.8% per year in LMICs and decreased by 1.0% per year in HICs. Conclusions: As measured in standard units in sales data, the rate of increase in global antibiotic consumption may be slowing. However, the trends appear to differ between countries and drugs. In the absence of routine surveillance of antibiotic use in many countries, these data provide important indicators of trends in consumption which should be confirmed in national and local studies of prescribing.Keywords
Funding Information
- Netherlands Ministry of Health, Welfare and Sport
This publication has 37 references indexed in Scilit:
- Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, ItalyJournal of Hospital Infection, 2018
- Global increase and geographic convergence in antibiotic consumption between 2000 and 2015Proceedings of the National Academy of Sciences, 2018
- Correction to global antibiotic consumption dataThe Lancet Infectious Diseases, 2017
- Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence SurveyClinical Infectious Diseases, 2017
- Antibiotic consumption by New Zealand children: exposure is near universal by the age of 5 yearsJournal of Antimicrobial Chemotherapy, 2017
- Use of antibiotics in children younger than two years in eight countries: a prospective cohort studyBulletin of the World Health Organization, 2016
- Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspectsArchives of Disease in Childhood, 2016
- Point prevalence survey of antimicrobial use in Chinese hospitals in 2012American Journal of Infection Control, 2016
- Burden of Hospital Acquired Infections and Antimicrobial Use in Vietnamese Adult Intensive Care UnitsPLOS ONE, 2016
- Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales dataThe Lancet Infectious Diseases, 2014